Cargando…
Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
Genomics-based neoantigen discovery can be enhanced by proteomic evidence, but there remains a lack of consensus on the performance of different quality control methods for variant peptide identification in proteogenomics. We propose to use the difference between accurately predicted and observed re...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145864/ https://www.ncbi.nlm.nih.gov/pubmed/32273506 http://dx.doi.org/10.1038/s41467-020-15456-w |